SCHEMBL573529

SCHEMBL573529

COC(=O)c1cc([N+](=O)[O-])c(Oc2ccccc2)c(S(=O)(=O)N(C)C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 1/20 0.51
MAPT P10636 3/20 0.49
POLB P06746 2/20 0.49
ALDH1A1 P00352 3/20 0.45
HPGD P15428 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
XDH P47989 1/20 0.43
USP10 Q14694 1/20 0.43
KMT2A Q03164 1/20 0.43
THRB P10828 3/20 0.42
GAA P10253 2/20 0.42
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
SLC10A6 Q3KNW5 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11850832 0.90 TPMT (0.45) VCAM1MAPTPOLBALDH1A1HPGD
SCHEMBL14882355 0.88 VCAM1 (0.64) VCAM1MAPTPOLBALDH1A1HPGD
SCHEMBL573787 0.87 VCAM1 (0.53) VCAM1MAPTPOLBALDH1A1HPGD
SCHEMBL11540771 0.85 POLB (0.61) VCAM1MAPTPOLBALDH1A1HPGD
SCHEMBL574029 0.84 VCAM1 (0.46) VCAM1MAPTPOLBALDH1A1HPGD
SCHEMBL573657 0.84 VCAM1 (0.46) VCAM1MAPTPOLBALDH1A1HPGD
SCHEMBL10222900 0.84 VCAM1 (0.46) VCAM1MAPTPOLBALDH1A1HPGD
SCHEMBL573278 0.82 ALDH1A1 (0.48) MAPTALDH1A1HPGDNPSR1GAA
SCHEMBL11546125 0.79 POLB (0.55) VCAM1MAPTPOLBALDH1A1HPGD
SCHEMBL573855 0.78 VCAM1 (0.52) VCAM1MAPTPOLBALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 WO disclosed